Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. (DIAN TU)

This study is currently recruiting participants.

Verified April 2013 by Washington University School of Medicine

Sponsor:

Collaborators:

Eli Lilly and Company

Hoffmann-La Roche

Alzheimer's Association

Information provided by (Responsible Party):

Washington University School of Medicine

ClinicalTrials.gov Identifier:

NCT01760005

First received: December 26, 2012

Last updated: April 11, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2016
Estimated Primary Completion Date:	July 2014 (Final data collection date for primary outcome measure)